The Amount of Evidence Needed to Support ERBB2 as a...

  • Main
  • 2019 / 08
  • The Amount of Evidence Needed to Support ERBB2 as a...
JAMA Oncology 2019 / 08

The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer

Raghav, Kanwal, Strickler, John H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2019.2985
Date:
August, 2019
File:
PDF, 44 KB
english, 2019
Conversion to is in progress
Conversion to is failed